{"id":489,"date":"2026-02-28T10:15:37","date_gmt":"2026-02-28T10:15:37","guid":{"rendered":"https:\/\/heartcareforyou.in\/blog\/aortic-stenosis-definition-clinical-context-and-cardiology-overview\/"},"modified":"2026-02-28T10:15:37","modified_gmt":"2026-02-28T10:15:37","slug":"aortic-stenosis-definition-clinical-context-and-cardiology-overview","status":"publish","type":"post","link":"https:\/\/heartcareforyou.in\/blog\/aortic-stenosis-definition-clinical-context-and-cardiology-overview\/","title":{"rendered":"Aortic Stenosis: Definition, Clinical Context, and Cardiology Overview"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Aortic Stenosis Introduction (What it is)<\/h2>\n\n\n\n<p>Aortic Stenosis is a condition where the aortic valve opening becomes narrowed.<br\/>\nIt is a type of valvular heart disease that increases resistance to blood leaving the left ventricle.<br\/>\nIt is commonly encountered during evaluation of a heart murmur, exertional symptoms, or heart failure.<br\/>\nIt is a core topic in cardiology because diagnosis and timing of valve intervention strongly influence outcomes.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Aortic Stenosis matters in cardiology (Clinical relevance)<\/h2>\n\n\n\n<p>Aortic Stenosis matters because it can be a progressive, mechanical obstruction to forward blood flow that the heart cannot fully compensate for indefinitely. As narrowing worsens, the left ventricle (LV) often adapts by thickening (hypertrophy) to generate higher pressure, which can preserve cardiac output for a time but may reduce compliance and contribute to elevated filling pressures.<\/p>\n\n\n\n<p>Clinically, Aortic Stenosis is important for several reasons:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Symptom interpretation and risk<\/strong>: Exertional chest discomfort, syncope (fainting), and shortness of breath can reflect limited ability to increase cardiac output during activity. When symptoms are attributable to significant valve obstruction, prognosis and management often change.<\/li>\n<li><strong>Diagnostic clarity<\/strong>: A systolic murmur is common in practice, but the underlying cause varies. Distinguishing Aortic Stenosis from other systolic murmurs (e.g., hypertrophic cardiomyopathy, mitral regurgitation) is central to accurate diagnosis.<\/li>\n<li><strong>Treatment planning<\/strong>: Valve replacement options include surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR). Selecting an approach depends on anatomy, comorbidities, procedural risk, and patient goals\u2014factors typically weighed by a multidisciplinary \u201cheart team.\u201d<\/li>\n<li><strong>Comorbid disease overlap<\/strong>: Aortic Stenosis often coexists with coronary artery disease, atrial fibrillation, hypertension, and chronic kidney disease, which can complicate symptom attribution, testing, and procedural decisions.<\/li>\n<\/ul>\n\n\n\n<p>For learners, Aortic Stenosis is a high-yield example of how anatomy (valve structure), physiology (pressure gradients and flow), physical exam findings, and echocardiography integrate into clinical reasoning.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Classification \/ types \/ variants<\/h2>\n\n\n\n<p>Aortic Stenosis can be classified in several clinically useful ways. No single scheme fits every scenario, so clinicians often combine etiology, anatomic level, and hemodynamic pattern.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">By cause (etiology)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Degenerative (calcific) Aortic Stenosis<\/strong>: Progressive calcification and thickening of valve cusps, often in older adults.<\/li>\n<li><strong>Congenital valve morphology (commonly bicuspid aortic valve)<\/strong>: A valve with two cusps instead of three can calcify earlier in life and may be associated with aortopathy (disease of the ascending aorta).<\/li>\n<li><strong>Rheumatic valve disease<\/strong>: Less common in many high-resource settings; can cause commissural fusion and may involve other valves (e.g., mitral).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">By anatomic level of obstruction<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Valvular Aortic Stenosis<\/strong>: Narrowing at the valve cusps (most common).<\/li>\n<li><strong>Subvalvular (subaortic) obstruction<\/strong>: Below the valve (e.g., discrete subaortic membrane, hypertrophic obstructive physiology).<\/li>\n<li><strong>Supravalvular obstruction<\/strong>: Above the valve (e.g., congenital narrowing of the ascending aorta).<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">By hemodynamic and clinical stage<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Severity spectrum<\/strong>: Often described as mild, moderate, or severe based on echocardiographic measures interpreted in clinical context (rather than a single number).<\/li>\n<li><strong>Flow-gradient patterns<\/strong>: Some patients have high gradients with preserved LV ejection fraction; others have <strong>low-flow, low-gradient<\/strong> patterns where gradients appear lower despite clinically important obstruction. This is one reason multiple echo parameters and clinical findings are considered together.<\/li>\n<li><strong>Symptomatic vs asymptomatic<\/strong>: Symptom status is a major branch point because it changes risk assessment and often influences procedural timing.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Relevant anatomy &amp; physiology<\/h2>\n\n\n\n<p>The <strong>aortic valve<\/strong> sits between the <strong>left ventricle<\/strong> and the <strong>ascending aorta<\/strong>. In normal physiology, it opens widely during systole to allow ejection and closes during diastole to prevent regurgitation back into the LV.<\/p>\n\n\n\n<p>Key physiologic concepts tied to Aortic Stenosis include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pressure generation and afterload<\/strong>: The LV must generate pressure high enough to overcome both systemic vascular resistance and any added resistance from the narrowed valve. Aortic Stenosis therefore increases LV afterload.<\/li>\n<li><strong>Left ventricular remodeling<\/strong>: Chronic pressure overload commonly leads to <strong>concentric hypertrophy<\/strong> (thicker LV walls). This can reduce LV compliance, contributing to higher diastolic pressures and symptoms of congestion even when systolic function looks preserved.<\/li>\n<li><strong>Coronary perfusion<\/strong>: Coronary blood flow largely occurs in diastole. Elevated LV diastolic pressure and hypertrophy can impair the gradient driving coronary perfusion, contributing to exertional angina even without obstructive coronary artery disease.<\/li>\n<li><strong>Stroke volume reserve<\/strong>: During exercise, a healthy heart increases stroke volume and heart rate. In significant Aortic Stenosis, fixed outflow obstruction can limit the ability to increase cardiac output, predisposing to exertional symptoms.<\/li>\n<li><strong>Conduction system proximity<\/strong>: The aortic valve annulus is near the conduction system. This matters particularly for TAVR, where conduction disturbances can occur due to mechanical interaction with nearby tissue.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Pathophysiology or mechanism<\/h2>\n\n\n\n<p>At its core, Aortic Stenosis is a <strong>mechanical narrowing<\/strong> that increases resistance to blood flow from the LV into the aorta.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Valve-level changes<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>In <strong>calcific disease<\/strong>, valve cusps progressively thicken and calcify, reducing leaflet mobility and effective orifice area.<\/li>\n<li>In <strong>bicuspid valves<\/strong>, altered leaflet stress and flow patterns may accelerate calcification and fibrosis.<\/li>\n<li>In <strong>rheumatic disease<\/strong>, commissural fusion and scarring can reduce opening.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Hemodynamic consequences<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pressure gradient across the valve<\/strong>: As the opening narrows, the LV must generate higher systolic pressure to eject blood. Clinically, this is reflected by increased Doppler velocities and pressure gradients on echocardiography (interpreted alongside flow and LV function).<\/li>\n<li><strong>Compensatory hypertrophy<\/strong>: The LV adapts to pressure overload by thickening. This can maintain systolic performance for a period but increases myocardial oxygen demand and may contribute to diastolic dysfunction.<\/li>\n<li><strong>Progression to decompensation<\/strong>: Over time, the LV may fail to compensate. Patients may develop reduced ejection fraction, rising filling pressures, pulmonary congestion, and functional decline.<\/li>\n<li><strong>Low-flow states<\/strong>: Some patients have reduced forward flow (stroke volume) due to LV dysfunction or small-cavity, stiff ventricles. In these settings, measured gradients may appear deceptively modest, so clinicians integrate multiple findings to determine whether stenosis is truly severe.<\/li>\n<\/ul>\n\n\n\n<p>The pace of progression and the relationship between anatomy, hemodynamics, and symptoms can vary by clinician and case.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Clinical presentation or indications<\/h2>\n\n\n\n<p>Common clinical scenarios where Aortic Stenosis is considered include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Incidental systolic murmur<\/strong> noted on routine examination<\/li>\n<li><strong>Exertional shortness of breath<\/strong> or reduced exercise tolerance<\/li>\n<li><strong>Exertional chest pressure\/discomfort<\/strong> (angina-like symptoms), with or without known coronary artery disease<\/li>\n<li><strong>Presyncope or syncope<\/strong> (near-fainting or fainting), especially with exertion<\/li>\n<li><strong>Heart failure presentation<\/strong>, including pulmonary congestion, lower-extremity edema, or fatigue<\/li>\n<li><strong>Abnormal echocardiogram<\/strong> performed for another reason (e.g., evaluation of hypertension, cardiomyopathy, or atrial fibrillation)<\/li>\n<li><strong>Pre-operative cardiac evaluation<\/strong> where a murmur or symptoms prompt valve assessment<\/li>\n<li><strong>Elderly patients with unexplained falls or functional decline<\/strong>, where exertional symptoms may be underreported<\/li>\n<\/ul>\n\n\n\n<p>Physical exam may suggest the diagnosis (e.g., crescendo\u2013decrescendo systolic murmur, delayed carotid upstroke), but imaging is typically required for confirmation and severity assessment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Diagnostic evaluation &amp; interpretation<\/h2>\n\n\n\n<p>Evaluation of Aortic Stenosis integrates symptoms, exam findings, and imaging\u2014most commonly echocardiography.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">History<\/h3>\n\n\n\n<p>Clinicians typically clarify:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Presence, onset, and triggers of exertional symptoms (dyspnea, chest discomfort, dizziness)<\/li>\n<li>Functional capacity changes over time<\/li>\n<li>Heart failure symptoms (orthopnea, paroxysmal nocturnal dyspnea)<\/li>\n<li>Past history of congenital valve disease, rheumatic fever, radiation therapy, or chronic kidney disease (risk factors vary)<\/li>\n<li>Comorbidities that can mimic or compound symptoms (coronary disease, lung disease, anemia)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Physical examination<\/h3>\n\n\n\n<p>Findings that may support Aortic Stenosis include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Systolic ejection murmur<\/strong> best heard at the right upper sternal border with radiation to the carotids (patterns vary)<\/li>\n<li><strong>Soft or delayed aortic component of S2<\/strong> (second heart sound) in more advanced disease<\/li>\n<li><strong>Carotid pulse changes<\/strong> (e.g., reduced amplitude, delayed upstroke), though this is examiner-dependent<\/li>\n<li>Signs of heart failure in decompensated cases<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Electrocardiogram (ECG) and chest imaging<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>ECG<\/strong> may show LV hypertrophy, repolarization changes, conduction abnormalities, or atrial fibrillation, but it is not diagnostic.<\/li>\n<li><strong>Chest radiograph<\/strong> can show cardiac silhouette changes, pulmonary congestion, or aortic calcification; it helps with differential diagnosis rather than grading stenosis.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Transthoracic echocardiography (TTE): cornerstone test<\/h3>\n\n\n\n<p>TTE with Doppler typically provides:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Valve anatomy (calcification, cusp mobility, bicuspid morphology when visible)<\/li>\n<li>LV size and systolic function<\/li>\n<li>Doppler-derived measures reflecting <strong>velocity and gradient<\/strong> across the valve<\/li>\n<li>Estimates of valve opening (effective orifice area) and overall hemodynamic impact<\/li>\n<li>Assessment of other valves and pulmonary pressures<\/li>\n<\/ul>\n\n\n\n<p>Interpretation is not based on a single measurement. Clinicians reconcile:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Flow dependence (low flow can lower gradient)<\/li>\n<li>Blood pressure at the time of the study<\/li>\n<li>LV function and geometry<\/li>\n<li>Measurement quality and technical factors<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Additional testing (selected cases)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Transesophageal echocardiography (TEE)<\/strong>: helpful when transthoracic windows are limited or for procedural planning.<\/li>\n<li><strong>Computed tomography (CT)<\/strong>: may support valve morphology assessment, quantify calcification in some protocols, and is commonly used for TAVR planning (annulus sizing, vascular access assessment).<\/li>\n<li><strong>Cardiac catheterization<\/strong>: used when noninvasive data are discordant, when coronary angiography is needed, or when invasive hemodynamics clarify severity.<\/li>\n<li><strong>Exercise testing<\/strong>: sometimes used in carefully selected, supervised settings to elicit symptoms or abnormal blood pressure response in patients thought to be asymptomatic; approaches vary by protocol and patient factors.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Management overview (General approach)<\/h2>\n\n\n\n<p>Management of Aortic Stenosis is guided by symptom status, hemodynamic severity, LV function, comorbidities, and procedural candidacy. The overview below is educational and intentionally non-prescriptive.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Conservative and surveillance approach<\/h3>\n\n\n\n<p>For less advanced disease or when symptoms are absent and stenosis is not hemodynamically severe, clinicians often focus on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Periodic clinical follow-up<\/strong> for symptom evolution<\/li>\n<li><strong>Repeat echocardiography<\/strong> at intervals based on severity and trajectory (varies by clinician and case)<\/li>\n<li><strong>Optimization of comorbid conditions<\/strong> (e.g., hypertension, atrial fibrillation, coronary disease, diabetes), which can influence symptoms and overall risk<\/li>\n<\/ul>\n\n\n\n<p>No medication reliably \u201copens\u201d a stenotic aortic valve. However, medical therapy may be used to treat accompanying conditions and heart failure physiology when present, with individualized attention to blood pressure, volume status, and overall hemodynamics.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Interventional and surgical options (definitive therapy for significant obstruction)<\/h3>\n\n\n\n<p>When obstruction is significant\u2014particularly when symptoms are attributable to the valve\u2014<strong>aortic valve replacement (AVR)<\/strong> becomes the definitive strategy.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Surgical aortic valve replacement (SAVR)<\/strong>: open surgical replacement using a mechanical or bioprosthetic valve. It may be combined with other procedures (e.g., coronary artery bypass grafting) when indicated.<\/li>\n<li><strong>Transcatheter aortic valve replacement (TAVR)<\/strong>: minimally invasive valve implantation via catheter-based techniques, commonly through transfemoral access. Suitability depends on anatomic factors (annulus size, vascular access, valve morphology) and patient-level risk\/benefit considerations.<\/li>\n<\/ul>\n\n\n\n<p><strong>Balloon aortic valvuloplasty<\/strong> may be used in selected scenarios (for example, as a bridge in unstable patients or specific clinical contexts), but the durability of benefit can be limited and practice varies by institution.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">\u201cHeart team\u201d decision-making<\/h3>\n\n\n\n<p>Many centers use a multidisciplinary approach involving cardiology, cardiac surgery, imaging specialists, anesthesiology, and others. This helps integrate:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Procedural feasibility and risk<\/li>\n<li>Expected symptom benefit and quality-of-life impact<\/li>\n<li>Valve choice considerations (durability expectations, anticoagulation implications)<\/li>\n<li>Patient preferences and goals of care<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Complications, risks, or limitations<\/h2>\n\n\n\n<p>Potential complications and limitations relate to the disease itself and, when applicable, to interventions. Many risks are context-dependent and vary by patient factors.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Complications of untreated or progressive Aortic Stenosis<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Heart failure<\/strong> (including pulmonary edema)<\/li>\n<li><strong>Syncope and injury risk<\/strong> related to exertional presyncope\/syncope<\/li>\n<li><strong>Angina<\/strong> and myocardial ischemia (with or without epicardial coronary disease)<\/li>\n<li><strong>Arrhythmias<\/strong>, including atrial fibrillation; advanced disease may be associated with conduction abnormalities<\/li>\n<li><strong>Sudden cardiac death risk<\/strong>, particularly in more advanced or symptomatic disease (risk magnitude varies)<\/li>\n<li><strong>Endocarditis<\/strong> (infection of the valve), an uncommon but serious complication<\/li>\n<li><strong>Bleeding tendency in some patients<\/strong> due to acquired von Willebrand factor abnormalities (often discussed in the context of gastrointestinal bleeding\/angiodysplasia); this association can be clinically relevant but varies<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Risks and limitations of valve interventions (SAVR\/TAVR)<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Stroke or transient neurologic events<\/strong><\/li>\n<li><strong>Bleeding and vascular complications<\/strong><\/li>\n<li><strong>Acute kidney injury<\/strong>, especially with contrast exposure and comorbid kidney disease<\/li>\n<li><strong>Conduction disturbances<\/strong> and possible need for permanent pacemaker (notably after TAVR, depending on anatomy and device factors)<\/li>\n<li><strong>Prosthetic valve dysfunction<\/strong> over time (structural valve deterioration, thrombosis, or paravalvular leak depending on valve type and context)<\/li>\n<li><strong>Endocarditis on prosthetic valves<\/strong>, a serious late complication<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Prognosis &amp; follow-up considerations<\/h2>\n\n\n\n<p>Prognosis in Aortic Stenosis depends on the <strong>severity of obstruction<\/strong>, <strong>presence of symptoms<\/strong>, <strong>LV function<\/strong>, comorbid conditions, and whether definitive valve intervention is performed when appropriate.<\/p>\n\n\n\n<p>General educational points include:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Asymptomatic, less severe disease<\/strong> can remain stable for a period, but progression is possible and follow-up focuses on detecting changes in symptoms, LV function, or hemodynamics.<\/li>\n<li><strong>Symptomatic, significant Aortic Stenosis<\/strong> is typically associated with higher risk of adverse outcomes compared with asymptomatic disease, which is why symptom assessment and attribution are emphasized.<\/li>\n<li><strong>LV dysfunction<\/strong> (reduced ejection fraction or evidence of adverse remodeling) can influence risk and the expected degree of recovery after intervention.<\/li>\n<li>After <strong>valve replacement<\/strong>, follow-up often includes clinical assessment, echocardiography to establish a post-procedure baseline, and monitoring for prosthesis-related issues or comorbidity management. Specific follow-up intervals vary by clinician and case.<\/li>\n<\/ul>\n\n\n\n<p>Patients\u2019 trajectories can differ substantially based on age, frailty, coronary disease burden, kidney function, lung disease, and procedural factors.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Aortic Stenosis Common questions (FAQ)<\/h2>\n\n\n\n<p><strong>Q: What does Aortic Stenosis mean in plain language?<\/strong><br\/>\nIt means the aortic valve does not open as widely as it should. This creates a bottleneck for blood leaving the left ventricle. The heart may need to pump harder to push blood through the narrowed opening.<\/p>\n\n\n\n<p><strong>Q: What causes Aortic Stenosis?<\/strong><br\/>\nCommon causes include age-related calcification of a normal three-cusp valve and earlier calcification of a bicuspid (two-cusp) valve. Rheumatic valve disease can also cause it in some populations. The most likely cause depends on age, history, and valve anatomy.<\/p>\n\n\n\n<p><strong>Q: How do clinicians determine how \u201csevere\u201d it is?<\/strong><br\/>\nSeverity is usually assessed with echocardiography using Doppler measurements that reflect how fast blood moves through the valve and the pressure difference across it. Clinicians also consider valve anatomy, LV function, and whether flow is reduced. Discordant findings can occur, so interpretation is often integrative rather than based on one value.<\/p>\n\n\n\n<p><strong>Q: What symptoms are most typical, and why do they happen?<\/strong><br\/>\nCommon symptoms include shortness of breath with exertion, chest discomfort, and dizziness or fainting, especially during activity. These reflect limited ability to increase forward blood flow and, in some cases, impaired coronary perfusion relative to myocardial demand. Symptoms can also be subtle and overlap with other conditions.<\/p>\n\n\n\n<p><strong>Q: If someone has Aortic Stenosis, do they always have a loud murmur?<\/strong><br\/>\nA murmur is common, but loudness does not perfectly track severity. Murmur intensity can be influenced by flow, chest wall characteristics, and exam technique. Imaging is needed to confirm the diagnosis and assess severity.<\/p>\n\n\n\n<p><strong>Q: Can medications treat Aortic Stenosis?<\/strong><br\/>\nMedications do not reverse the fixed narrowing of the valve. They may be used to manage associated conditions such as hypertension, atrial fibrillation, coronary disease, or heart failure physiology. The overall plan depends on the valve severity and the broader clinical picture.<\/p>\n\n\n\n<p><strong>Q: What is the difference between TAVR and surgical valve replacement?<\/strong><br\/>\nTAVR places a new valve using catheter-based techniques, often through an artery in the leg, while surgical replacement involves open surgery to remove and replace the valve. Choice depends on anatomy, comorbidities, procedural risk, expected durability considerations, and patient preferences. Many centers use a heart team model to guide selection.<\/p>\n\n\n\n<p><strong>Q: How is Aortic Stenosis monitored over time?<\/strong><br\/>\nMonitoring typically includes periodic symptom review, physical examination, and repeat echocardiography to track valve function and LV response. The timing of follow-up varies by protocol and patient factors. New or changing symptoms generally prompt reassessment.<\/p>\n\n\n\n<p><strong>Q: What should someone expect after a valve replacement?<\/strong><br\/>\nMany patients experience improved exercise tolerance and reduced symptoms when the valve obstruction is relieved, though recovery varies. Follow-up includes checking valve performance, managing comorbidities, and monitoring for complications such as rhythm issues or prosthetic valve problems. Rehabilitation and activity progression are individualized.<\/p>\n\n\n\n<p><strong>Q: Does everyone with Aortic Stenosis need a procedure right away?<\/strong><br\/>\nNot necessarily. Some people have mild or moderate disease that is monitored, while others have more significant obstruction where valve replacement becomes a key consideration, especially if symptoms are attributable to the valve. Timing decisions depend on severity, symptoms, LV function, and overall risk assessment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Aortic Stenosis is a condition where the aortic valve opening becomes narrowed. It is a type of valvular heart disease that increases resistance to blood leaving the left ventricle. It is commonly encountered during evaluation of a heart murmur, exertional symptoms, or heart failure. It is a core topic in cardiology because diagnosis and timing of valve intervention strongly influence outcomes.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-489","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/489","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/comments?post=489"}],"version-history":[{"count":0,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/posts\/489\/revisions"}],"wp:attachment":[{"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/media?parent=489"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/categories?post=489"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/heartcareforyou.in\/blog\/wp-json\/wp\/v2\/tags?post=489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}